Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Board Appointment

1 Feb 2005 12:00

Cello Group plc01 February 2005 1 February 2005 Cello Group plc Board Appointment The board of Cello Group plc ("Cello") announces the appointment of Mark Bentleyas Group Finance Director and Company Secretary. It is expected that he willjoin the board in late April, subject to existing contractual obligations. Mark Bentley (34) is currently Chief Operating Officer of Citigate Dewe RogersonLimited and Finance Director of Citigate SMARTS Group, part of Incepta Groupplc. Prior to this, he was Financial Projects Manager at Hodder Headline plc.He qualified as a chartered accountant with PriceWaterhouseCoopers in 1996. Commenting on his appointment, Kevin Steeds, Chairman of Cello said: "We lookforward to welcoming Mark to the Group. He combines the traditional professionalfinancial background with some excellent operational experience in the marketingservices industry. I am sure he will play a key role in the future growth plansof Cello" - ENDS - Enquiries: Kevin Steeds - Chairman - Cello Group plc Tel: 020 7324 6120 Adrian Duffield - College Hill Tel: 020 7457 2020 Notes to Editors:- (www.cellogroup.co.uk) Cello Group plc, a newly incorporated marketing services group which listed onAIM in November 2004 and comprises four businesses which operate in threedifferent niches of the marketing services sector: - healthcare market research,direct and database marketing and brand advertising. Each share significantorganic and acquisitive growth potential; blue chip client lists and a longtrack record of client loyalty; experienced, high quality management teams;profitability; and potential for enhancing gross margins. Market research • Insight is a specialist healthcare market research business employing some 75 people and has offices in central London and New Jersey. Its clients include GlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals, NovoNordisk, Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp and Dohme. Brand advertising • Leith is the largest and most successful advertising agency in Scotland employing 60 people. The agency has been voted Scottish Agency of the Year for the last five years. Leith opened a London office in 2000 which has grown from a start-up to 25 people. Leith's major clients are Standard Life, Irn Bru, Scottish Executive, Standard Life Bank, Hotpoint, Goodfellas Pizza and Carling. Direct marketing and database management • Target, based in Cheltenham, is the UK's leading direct marketing consultancy specialising in the "not-for-profit" and charity sector. The agency works for five of the top 20 charities in the UK and employs some 80 people. Target has also expanded its offer to the "grey market", working for clients such as The National Trust, Saga Holidays and Which? Limited. Target's subsidiary, Talking Numbers is a leading database management and analytics company. • Navigator Responsive Advertising is Scotland's number one direct marketing company employing 40 people and provides responsive communication solutions for a wide range of clients. Areas of expertise include strategic planning, database marketing, customer relationship management and creative solutions - utilising a wide range of media that includes direct mail, press, outdoor, radio, DRTV and electronic media. Navigator was a winner of eight industry awards in 2004. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Jan 20157:00 amRNSPRE-CLOSE TRADING STATEMENT
16th Jan 20155:15 pmRNSBlocklisting Interim Review
6th Jan 20154:50 pmRNSTotal Voting Rights
9th Dec 20147:00 amRNSAcquisition of Worldwide Promedica Inc
28th Nov 20141:10 pmRNSTotal Voting Rights
3rd Nov 201410:58 amRNSTotal Voting Rights
2nd Oct 201410:59 amRNSDirector/PDMR Shareholding
1st Oct 20141:05 pmRNSTotal Voting Rights
19th Sep 20144:10 pmRNSDirector/PDMR Shareholding
17th Sep 20147:00 amRNSInterim Results
1st Sep 20147:00 amRNSHolding(s) in Company
29th Aug 20147:00 amRNSTotal Voting Rights
31st Jul 20147:00 amRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Update
1st Jul 20143:54 pmRNSBlocklisting Interim Review
1st Jul 201412:24 pmRNSTotal Voting Rights
25th Jun 20141:27 pmRNSIssue of Equity
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
3rd Jun 20142:02 pmRNSDirector/PDMR Shareholding
30th May 20147:00 amRNSTotal Voting Rights
13th May 20141:00 pmRNSResults of Annual General Meeting
13th May 20147:00 amRNSAGM STATEMENT
13th May 20147:00 amRNSAcquisition of iS Healthcare Dynamics
8th May 20147:00 amRNSAdditional listing/TVR
30th Apr 20143:25 pmRNSTotal Voting Rights
25th Apr 20147:00 amRNSAcquisition of Line Digital
14th Apr 201412:17 pmRNSAnnual Report & Accounts 2013 & Notice of AGM
31st Mar 20147:00 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results for the Year Ended 31 Dec 2013
28th Feb 20147:00 amRNSTotal Voting Rights
3rd Feb 20147:00 amRNSTotal Voting Rights
22nd Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
7th Jan 20142:17 pmRNSBlocklisting Interim Review
17th Oct 201310:53 amRNSDirector/PDMR Shareholding
11th Oct 201311:36 amRNSTransaction in Own Shares
11th Oct 20137:00 amRNSDirector/PDMR Shareholding
1st Oct 20132:58 pmRNSTotal Voting Rights
27th Sep 201311:42 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
18th Sep 20137:00 amRNSInterim Results
13th Sep 201312:07 pmRNSIssue of Equity
17th Jul 20137:00 amRNSTrading update
8th Jul 201312:26 pmRNSTransaction in Own Shares
4th Jul 201310:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSBlock Listing Application
3rd Jun 20133:12 pmRNSDirector/PDMR Shareholding
31st May 20139:00 amRNSTotal Voting Rights
21st May 201312:53 pmRNSDirector/PDMR Shareholding
15th May 201312:12 pmRNSHolding(s) in Company
14th May 20132:49 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.